Lgl Partners, LLC Novo Nordisk A S Transaction History

Lgl Partners, LLC

$634 Million
Q3 2024

A detailed history of Lgl Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lgl Partners, LLC holds 4,555 shares of NVO stock, worth $467,479. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,555

Previous 5,119 11.02%

Holding current value

$467,479

Previous $730,000 25.75%

% of portfolio

0.09%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $67,155 - $82,016	-564 Reduced 11.02%	4,555 $542,000
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $47,734 - $57,147	-389 Reduced 7.06%	5,119 $730,000
Q1 2024 Apr 30, 2024	BUY	$102.11 - $135.92 $29,816 - $39,688	292 Added 5.6%	5,508 $707,000
Q4 2023 Feb 05, 2024	BUY	$87.78 - $105.45 $8,778 - $10,545	100 Added 1.95%	5,216 $539,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $232,624 - $510,423	2,558 Added 100.0%	5,116 $465,000
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $119,238 - $143,385	-901 Reduced 26.05%	2,558 $407,000
Q3 2022 Nov 09, 2022	SELL	$95.28 - $116.93 $6,669 - $8,185	-70 Reduced 1.98%	3,459 $345,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $71,958 - $84,901	-697 Reduced 16.49%	3,529 $393,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $22,809 - $27,572	245 Added 6.15%	4,226 $469,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $162,592 - $205,350	-1,926 Reduced 32.61%	3,981 $382,000
Q1 2021 May 04, 2021	BUY	$67.06 - $75.82 $12,070 - $13,647	180 Added 3.14%	5,907 $398,000
Q3 2020 Nov 04, 2020	SELL	$63.69 - $70.22 $3,248 - $3,581	-51 Reduced 0.88%	5,727 $398,000
Q2 2020 Aug 10, 2020	SELL	$58.54 - $67.94 $112,279 - $130,308	-1,918 Reduced 24.92%	5,778 $378,000
Q1 2020 May 13, 2020	BUY	$49.46 - $64.78 $10,930 - $14,316	221 Added 2.96%	7,696 $463,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $39,695 - $44,614	835 Added 12.58%	7,475 $386,000
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $6,784 - $7,608	145 Added 2.23%	6,640 $339,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $301,108 - $341,831	6,495 New	6,495 $340,000

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgl Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgl Partners, LLC with notifications on news.

Account